Over the past decade at ExecMind, working closely with founders across Europe’s medtech and biotech ecosystems, I’ve noticed a pattern that repeats itself with almost predictable clarity:
Innovation rarely slows down because the science is wrong. It slows down because the founder is expected to carry everything.
Vision. Operations. Fundraising. Strategy. Regulatory pressure. Team stability.
All on one set of shoulders.
In the earliest days, this works.
Founders are resilient, highly driven, and deeply connected to their technology. But once the company starts moving, clinical planning begins, regulatory expectations rise, investors demand predictability, and the first real manufacturing decisions appear, the weight becomes too heavy.
I saw it a decade ago when I founded ExecMind, and I see it even more clearly today: early-stage life science founders simply were not thinking about hiring a COO. It “felt too early,” as they focused on grants, prototypes, trials, data, and partnerships, while also trying to hire, onboard, manage suppliers, oversee quality, ensure compliance, and somehow still drive the company forward.
The result was always the same:
Exhaustion. Overwhelm. A brilliant vision without consistent execution.
Does this sound familiar?
Where Companies Stall and Why the COO Becomes the Turning Point
Across growth-stage companies, I’ve seen one repeated truth: science takes you far, but operations determine whether you reach the market.
And this is where the right COO becomes transformational.
1. Turning solid science into a scalable engine.
Founders are visionaries. COOs are architects of structure. When the two align, the organisation stops relying on ad-hoc heroics and starts operating with rhythm and clarity.
2. Reducing risk - long before investors ask for it
A professional COO brings consistency: governance, documentation, reporting, quality systems, repeatability. That’s exactly why VCs see the COO role as a strategic de-risking mechanism, not simply an operational hire.
3. Shortening timelines that directly affect valuation
In medtech and biotech, delays aren’t just inconvenient, they are costly. COOs prevent bottlenecks from turning into stalled trials, manufacturing issues, or regulatory slippage.
4. Removing the founder as the single point of failure
Founders keep vision, strategy, and investor relationships; COOs take over QA/RA coordination, supply chain, vendor oversight, and operational discipline. Once this partnership clicks, a founder’s bandwidth expands dramatically.
5. Making the company truly investable
Investors don’t fund potential alone, they fund the ability to deliver. What Investors sense instinctively is: bottlenecks, silos, rising burn rate, unpredictable execution, and regulatory exposure.
The right COO removes these doubts.
When Should a Founder Actually Consider a COO?
Across hundreds of leadership searches, the same readiness signals appear:
· When the company moves beyond proof of concept
· As clinical or regulatory work begins
· When manufacturing, QA/RA, or supply chain complexity increases
· When commercialisation comes into view
· Immediately after securing a major funding round
These are the moments when operational leadership stops being optional and becomes strategically necessary.
What a COO Unlocks for the Organisation
A high-calibre COO changes the company from the inside out:
· Investor conversations become clearer and more confident
· Silos disappear and teams finally operate in sync
· Execution becomes predictable, not dependent on founder energy
· The company grows beyond the founder’s personal capacity
· Milestones stop slipping — and valuation stabilises or grows
It’s the structural maturity needed to scale in an industry where timelines, risk, and quality matter more than in any other sector.
If You’re a Founder Reading This…
And you feel the fatigue, the pressure, the sense that you are the bottleneck - even though you’re working harder than ever.
You’re not alone. You’re simply at the natural next stage of company growth, where operational leadership becomes your greatest strategic advantage.
If you want to assess whether it’s truly the right moment, or define the profile your company needs next, or simply talk through your bottlenecks confidentially - we’re here.
ExecMind — Life Science Executive Search
karolina.jarosinska@execmind.com
Discreet. Insightful. Results-driven.
